Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ferdinando Stelio Buonanno, M.D.

Co-Author

This page shows the publications co-authored by Ferdinando Buonanno and Igor Palacios.
Connection Strength

1.461
  1. Efficacy and safety of percutaneous patent foramen ovale closure in patients with a hypercoagulable disorder. Catheter Cardiovasc Interv. 2021 10; 98(4):800-807.
    View in: PubMed
    Score: 0.236
  2. Effect of Residual Interatrial Shunt on Migraine Burden After Transcatheter Closure of Patent Foramen Ovale. JACC Cardiovasc Interv. 2020 02 10; 13(3):293-302.
    View in: PubMed
    Score: 0.215
  3. Long-term experience and outcomes with transcatheter closure of patent foramen ovale. JACC Cardiovasc Interv. 2013 Nov; 6(11):1176-83.
    View in: PubMed
    Score: 0.139
  4. The brain's heart - therapeutic opportunities for patent foramen ovale (PFO) and neurovascular disease. Pharmacol Ther. 2013 Aug; 139(2):111-23.
    View in: PubMed
    Score: 0.133
  5. Management of residual shunts after initial percutaneous patent foramen ovale closure: a single center experience with immediate and long-term follow-up. Catheter Cardiovasc Interv. 2010 Jul 01; 76(1):145-50.
    View in: PubMed
    Score: 0.110
  6. May-Thurner syndrome in patients with cryptogenic stroke and patent foramen ovale: an important clinical association. Stroke. 2009 Apr; 40(4):1502-4.
    View in: PubMed
    Score: 0.100
  7. Contrast M-mode power Doppler ultrasound in the detection of right-to-left shunts: utility of submandibular internal carotid artery recording. J Neuroimaging. 2003 Oct; 13(4):315-23.
    View in: PubMed
    Score: 0.069
  8. Percutaneous transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Circulation. 2002 Aug 27; 106(9):1121-6.
    View in: PubMed
    Score: 0.064
  9. Effect of Patent Foramen Ovale Closure After Stroke on Circulatory Biomarkers. Neurology. 2021 07 13; 97(2):e203-e214.
    View in: PubMed
    Score: 0.059
  10. Reply: Shouldn't Patients With Paradoxical Emboli and Thrombophilia Be Given Anticoagulant Agents? JACC Cardiovasc Interv. 2021 03 08; 14(5):583-584.
    View in: PubMed
    Score: 0.058
  11. Patent Foramen Ovale Attributable Cryptogenic Embolism With Thrombophilia Has Higher Risk for Recurrence and Responds to Closure. JACC Cardiovasc Interv. 2020 12 14; 13(23):2745-2752.
    View in: PubMed
    Score: 0.057
  12. Residual Shunt After Patent Foramen Ovale Closure and Long-Term Stroke Recurrence. Ann Intern Med. 2020 12 01; 173(11):946-947.
    View in: PubMed
    Score: 0.057
  13. Residual Shunt After Patent Foramen Ovale Closure and Long-Term Stroke Recurrence: A Prospective Cohort Study. Ann Intern Med. 2020 06 02; 172(11):717-725.
    View in: PubMed
    Score: 0.055
  14. Patent foramen ovale (PFO), stroke and pregnancy. J Investig Med. 2016 06; 64(5):992-1000.
    View in: PubMed
    Score: 0.041
  15. Proteomic signatures of serum albumin-bound proteins from stroke patients with and without endovascular closure of PFO are significantly different and suggest a novel mechanism for cholesterol efflux. Clin Proteomics. 2015; 12(1):2.
    View in: PubMed
    Score: 0.038
  16. Heart-brain signaling in patent foramen ovale-related stroke: differential plasma proteomic expression patterns revealed with a 2-pass liquid chromatography-tandem mass spectrometry discovery workflow. J Investig Med. 2012 Dec; 60(8):1122-30.
    View in: PubMed
    Score: 0.033
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.